Log in
Enquire now
RepliCel Life Sciences

RepliCel Life Sciences

RepliCel Life Sciences is a biotechnology company developing regenerative medicines primarily using autologous cell therapy.

OverviewStructured DataIssuesContributors

Contents

replicel.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Cell therapy
Cell therapy
Immunotherapy
Immunotherapy
Stem cell
Stem cell
Healthcare
Healthcare
Regenerative medicine
Regenerative medicine
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
...
Location
Vancouver
Vancouver
British Columbia
British Columbia
Canada
Canada
Pitchbook URL
pitchbook.com/profiles.../43226-47
Email Address
info@replicel.com
Phone Number
+16042488730
Total Funding Amount (USD)
594,050
Latest Funding Round Date
April 25, 2012
Patents Assigned (Count)
5
Country
Canada
Canada

Other attributes

Company Operating Status
Active

RepliCel Life Sciences is a biotechnology company developing regenerative medicines primarily using autologous cell therapy that is headquartered in Vancouver, British Columbia and was founded in 2010 by Rolf Hoffmann and

Kevin McElwee.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

A cure for baldness? Stem cell researchers race to regenerate follicles from hair resistant to loss

Erin Ellis

https://www.replicel.com/news/a-cure-for-baldness-stem-cell-researchers-race-to-regenerate-follicles-from-hair-resistant-to-loss

Web

References

Find more companies like RepliCel Life Sciences

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.